| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/12/2011 | WO2011056447A2 Methods and kits for preventing hypoglycemia |
| 05/12/2011 | WO2011056061A1 A composition for promoting health of cardiovascular system |
| 05/12/2011 | WO2011056037A2 Pharmaceutical composition containing, as active ingredients, lindera erythrocarpa extracts, fractions thereof, or compounds separated from the extracts |
| 05/12/2011 | WO2011055770A1 Fused heterocyclic compound |
| 05/12/2011 | WO2011055550A1 Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent |
| 05/12/2011 | WO2011054301A1 Use of danshensu, notoginsenoside r1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder |
| 05/12/2011 | WO2011054285A1 Melanocortin receptor agonist, preparation method and use thereof |
| 05/12/2011 | WO2011054182A1 Sodium transhinone iia sulfonate hydrate and preparation method and use thereof |
| 05/12/2011 | WO2011034834A3 Pharmaceutical compositions which inhibit fkbp52-mediated regulation of androgen receptor function and methods of using same |
| 05/12/2011 | WO2011011300A3 Differentiation of human embryonic stem cells |
| 05/12/2011 | WO2011009115A3 Combination therapies for the treatment of obesity |
| 05/12/2011 | WO2011008490A3 Combination therapies for the treatment of obesity |
| 05/12/2011 | WO2011003062A3 Probiotic compositions and processes thereof |
| 05/12/2011 | US20110112201 Hydroxytyrosol benefits mitochondria |
| 05/12/2011 | US20110112186 Diagnostic methods |
| 05/12/2011 | US20110112184 Compounds with glycidic structure active in the therapy of systemic and local inflammation |
| 05/12/2011 | US20110112171 Compositions and their uses directed to ptpru |
| 05/12/2011 | US20110112165 Atorvastatin-aliskiren |
| 05/12/2011 | US20110112161 Indole and indazole analogs as glycogen synthase activators |
| 05/12/2011 | US20110112158 Benzisoxazole analogs as glycogen synthase activators |
| 05/12/2011 | US20110112151 Compound capable of inhibiting 11-beta hydroxysteriod dehydrogenase |
| 05/12/2011 | US20110112148 Indoline compounds |
| 05/12/2011 | US20110112147 Indazolone analogs as glycogen synthase activators |
| 05/12/2011 | US20110112142 Novel estrogen receptor ligands |
| 05/12/2011 | US20110112139 Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/12/2011 | US20110112122 EPIMINOCYCLOALKYL[b] INDOLE DERIVATIVES AS SEROTONIN SUB-TYPE 6 (5-HT6) MODULATORS AND USES THEREOF |
| 05/12/2011 | US20110112120 Heteromonocyclic compound and use thereof |
| 05/12/2011 | US20110112111 Drug combinations comprising a dgat inhibitor and a ppar-agonist |
| 05/12/2011 | US20110112107 Substituted 6-(1-piperazinyl)-pyridazines as 5-ht6 receptor antagonists |
| 05/12/2011 | US20110112106 Tricyclic inhibitors of 5-lipoxygenase |
| 05/12/2011 | US20110112105 Substituted heterocycle fused gamma-carbolines solid |
| 05/12/2011 | US20110112097 Substituted imidazoline-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof |
| 05/12/2011 | US20110112092 Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 05/12/2011 | US20110112091 Derivatives of tetrabromobenzimidazole, a process for the preparation thereof, a pharmaceutical composition comprising the same, a methof of using the same, a method for modulating or regulating serine/threonine kinases, and serine/threonine kinases modulating agent |
| 05/12/2011 | US20110112090 Depsipeptides and Their Therapeutic Use |
| 05/12/2011 | US20110112082 Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 05/12/2011 | US20110112080 Oxazoline derivatives |
| 05/12/2011 | US20110112079 Phosphodiesterase inhibitors |
| 05/12/2011 | US20110112072 Thiophenyl and pyrrolyl azepines as serotonin 5-ht2c receptor ligands and uses thereof |
| 05/12/2011 | US20110112071 Novel heterocyclidene acetamide derivative |
| 05/12/2011 | US20110112067 Inhibitors of the Human Aldosterone Sythase CYP11B2 |
| 05/12/2011 | US20110112065 Modulators of dopamine neurotransmission |
| 05/12/2011 | US20110112060 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 05/12/2011 | US20110112058 Novel modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer |
| 05/12/2011 | US20110112056 Use of Carbon-2-Modified-Vitamin D Analogs to Induce the Formation of New Bone |
| 05/12/2011 | US20110112054 Organophosphorous Compounds for the Activation of Gamma/Delta T Cells |
| 05/12/2011 | US20110112051 Dipeptidyl Peptidase-IV Inhibitors |
| 05/12/2011 | US20110112050 Separation of polysaccharides by charge density gradient |
| 05/12/2011 | US20110112047 Methods for enhancing muscle performance and tone |
| 05/12/2011 | US20110112017 Compositions, methods and uses for treating diabetes |
| 05/12/2011 | US20110112016 Compositions and methods for modulating the immune system |
| 05/12/2011 | US20110112015 Use of glis3 for preparing functional pancreatic beta-cells |
| 05/12/2011 | US20110112014 Supplementation of propane-1,2,3-triol and water in fasting subjects |
| 05/12/2011 | US20110111071 Effects of dichrostachys glomerata dg, hypodaphnis zenkeri hz, and xylopia aethiopica xa on various cardiovascular risk factors and metabolic syndrome |
| 05/12/2011 | US20110111069 Compositions that lower cytosolic nadh level to mimic calorie restriction for life extension and methods |
| 05/12/2011 | US20110111046 N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors |
| 05/12/2011 | US20110111042 Self-microemulsifying systems incorporated into liquid core microcapsules |
| 05/12/2011 | US20110111038 Process for producing a stable concentrated dietary supplement and supplement produced thereby |
| 05/12/2011 | US20110111033 Hydrogel with covalently crosslinked core |
| 05/12/2011 | US20110111030 Method of Producing Progenitor Cells from Differentiated Cells |
| 05/12/2011 | US20110111023 Prevention of type 1 diabetes by administration of gliadin |
| 05/12/2011 | US20110111022 Pharmaceutical formulation |
| 05/12/2011 | US20110111021 Pharmaceutical preparation |
| 05/12/2011 | US20110110961 Prolyl hydroxylase inhibitors |
| 05/12/2011 | US20110110957 Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use |
| 05/12/2011 | US20110110949 Nesfatin-1 specific antibody and the use thereof, and nesfatin specific antibody and the use thereof |
| 05/12/2011 | US20110110946 Soluble receptor br43x2 and methods of using |
| 05/12/2011 | US20110110943 Soluble receptor br43x2 and methods of using |
| 05/12/2011 | US20110110938 Compositions and methods for the treatment of immune related diseases |
| 05/12/2011 | US20110110910 Proteases for Pharmaceutical Use |
| 05/12/2011 | US20110110909 Human facilitating cells |
| 05/12/2011 | US20110110908 Treatment of disease conditions via administration of dna repair enzyme |
| 05/12/2011 | US20110110904 Nutritional composition containing oligosaccharide mixture |
| 05/12/2011 | US20110110901 Methods of long-term culture of eukaryotic cells and uses thereof |
| 05/12/2011 | US20110110899 Combined Chemical and Genetic Approaches for Generation of Induced Pluripotent Stem Cells |
| 05/12/2011 | US20110110882 Cross-linked compositions |
| 05/12/2011 | US20110110855 Novel ghrelin analogues |
| 05/12/2011 | DE102009053157A1 Arzneimittel enthaltend Cholin Medicines containing choline |
| 05/12/2011 | CA2781322A1 Use of danshensu, notoginsenoside r1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder |
| 05/12/2011 | CA2780362A1 Administration of plant expressed oral tolerance agents |
| 05/12/2011 | CA2779948A1 Carboxy oxazole or thiazole compounds as dgat-1 inhibitors useful for the treatment of obesity |
| 05/12/2011 | CA2779889A1 A method to enhance endurance |
| 05/12/2011 | CA2778806A1 Methods and kits for preventing hypoglycemia |
| 05/12/2011 | CA2778161A1 Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline |
| 05/12/2011 | CA2773353A1 Oligomer-calcimimetic conjugates and related compounds |
| 05/11/2011 | EP2319870A2 Human antibodies that bind human IL-12 and methods for producing |
| 05/11/2011 | EP2319859A2 Spatially-defined macrocyclic compounds useful for drug discovery |
| 05/11/2011 | EP2319841A1 (5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative |
| 05/11/2011 | EP2319838A1 Therapeutic Molecules and Methods-1 |
| 05/11/2011 | EP2319835A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group |
| 05/11/2011 | EP2319826A1 Succinate salt of O-desmethyl-venlafaxin |
| 05/11/2011 | EP2319581A1 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy |
| 05/11/2011 | EP2319523A1 Serine protease inhibitors |
| 05/11/2011 | EP2319513A1 Nicotinic acid compositons for treating hyperlipidemia and related methods therefor |
| 05/11/2011 | EP2319509A1 Method of Inhibiting remnant lipoprotein production |
| 05/11/2011 | EP2319508A1 Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism |
| 05/11/2011 | EP2319501A1 Pharmaceutical formulations for carrier-mediated transport statins and uses thereof |
| 05/11/2011 | EP2319493A2 Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent |
| 05/11/2011 | EP2318415A1 Oxazolopyrimidines as edg-1 receptor agonists |
| 05/11/2011 | EP2318404A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |